Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study.

Sperling RS, Shapiro DE, McSherry GD, Britto P, Cunningham BE, Culnane M, Coombs RW, Scott G, Van Dyke RB, Shearer WT, Jimenez E, Diaz C, Harrison DD, Delfraissy JF.

AIDS. 1998 Oct 1;12(14):1805-13.

PMID:
9792381
2.

HIV infection and zidovudine use in childbearing women.

Sia J, Paul S, Martin RM, Cross H.

Pediatrics. 2004 Dec;114(6):e707-12. Epub 2004 Nov 15.

PMID:
15545619
3.

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, et al.

N Engl J Med. 1994 Nov 3;331(18):1173-80.

4.

Effect of prenatal zidovudine on disease progression in perinatally HIV-1-infected infants.

de Souza RS, Gómez-Marín O, Scott GB, Guasti S, O'Sullivan MJ, Oliveira RH, Mitchell CD.

J Acquir Immune Defic Syndr. 2000 Jun 1;24(2):154-61.

PMID:
10935691
5.

Short course zidovudine maternal treatment in HIV-1 vertical transmission: randomized controlled multicenter trial.

Limpongsanurak S, Thaithumyanon P, Chaithongwongwatthana S, Thisyakorn U, Ruxrungtham K, Kongsin P, Tarounotai U, Chantheptaewan N, Triratwerapong T, Ubolyam S, Phanuphak P, Virutamasen P, Hanwanich M, Hawanon P, Chulasugondha P.

J Med Assoc Thai. 2001 Jun;84 Suppl 1:S338-45.

PMID:
11529355
6.

Maternal and infant factors predicting disease progression in human immunodeficiency virus type 1-infected infants. Women and Infants Transmission Study Group.

Rich KC, Fowler MG, Mofenson LM, Abboud R, Pitt J, Diaz C, Hanson IC, Cooper E, Mendez H.

Pediatrics. 2000 Jan;105(1):e8.

PMID:
10617745
7.

Zidovudine.

Sperling R.

Infect Dis Obstet Gynecol. 1998;6(5):197-203. Review.

8.

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, O'Sullivan MJ, Van Dyke RB, Jimenez E, Rouzioux C, Flynn PM, Sullivan JL.

N Engl J Med. 1996 Nov 28;335(22):1621-9.

9.

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, Hall D, Gigliotti M, Robinson P, Boshoff L, Sullivan JL; South African Intrapartum Nevirapine Trial (SAINT) Investigators.

J Infect Dis. 2003 Mar 1;187(5):725-35. Epub 2003 Feb 24.

PMID:
12599045
10.

A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.

Thistle P, Spitzer RF, Glazier RH, Pilon R, Arbess G, Simor A, Boyle E, Chitsike I, Chipato T, Gottesman M, Silverman M.

Clin Infect Dis. 2007 Jan 1;44(1):111-9. Epub 2006 Nov 22.

PMID:
17143826
11.

Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.

Clin Infect Dis. 2008 Feb 15;46(4):611-21. doi: 10.1086/526780.

PMID:
18197758
12.

HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.

Welles SL, Pitt J, Colgrove R, McIntosh K, Chung PH, Colson A, Lockman S, Fowler MG, Hanson C, Landesman S, Moye J, Rich KC, Zorrilla C, Japour AJ.

AIDS. 2000 Feb 18;14(3):263-71.

PMID:
10716502
13.

Oral zidovudine during labor to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood. Bangkok Collaborative Perinatal HIV Transmission Study Group.

Bhadrakom C, Simonds RJ, Mei JV, Asavapiriyanont S, Sangtaweesin V, Vanprapar N, Moore KH, Young NL, Hannon WH, Mastro TD, Shaffer N.

AIDS. 2000 Mar 31;14(5):509-16.

PMID:
10780713
14.

Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa: DITRAME ANRS 049a trial.

Leroy V, Montcho C, Manigart O, Van de Perre P, Dabis F, Msellati P, Meda N, You B, Simonon A, Rouzioux C; DITRAME Study Group.

AIDS. 2001 Mar 9;15(4):517-22.

PMID:
11242149
15.

Effect of pregnancy and zidovudine therapy on viral load in HIV-1-infected women.

Melvin AJ, Burchett SK, Watts DH, Hitti J, Hughes JP, McLellan CL, King PD, Johnson EJ, Williams BL, Frenkel LM, Coombs RW.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Mar 1;14(3):232-6.

PMID:
9117455
16.

Effect of zidovudine treatment in late pregnancy on HIV-1 in utero transmission.

Taneepanichskul S, Sirinavin S, Phuapradit W, Chaturachinda K.

Aust N Z J Obstet Gynaecol. 1997 Aug;37(3):329-31.

PMID:
9325519
17.

Safety of late in utero exposure to zidovudine in infants born to human immunodeficiency virus-infected mothers: Bangkok. Bangkok Collaborative Perinatal HIV Transmission Study Group.

Chotpitayasunondh T, Vanprapar N, Simonds RJ, Chokephaibulkit K, Waranawat N, Mock P, Stat MA, Chuachoowong R, Young N, Mastro TD, Shaffer N.

Pediatrics. 2001 Jan;107(1):E5.

PMID:
11134469
18.
19.

A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators.

Lallemant M, Jourdain G, Le Coeur S, Kim S, Koetsawang S, Comeau AM, Phoolcharoen W, Essex M, McIntosh K, Vithayasai V.

N Engl J Med. 2000 Oct 5;343(14):982-91.

20.

Maternal characteristics associated with antenatal, intrapartum, and neonatal zidovudine use in four US cities, 1994-1998.

Orloff SL, Bulterys M, Vink P, Nesheim S, Abrams EJ, Schoenbaum E, Palumbo P, Steketee RW, Simonds RJ; Perinatal AIDS Collaborative Transmission Study.

J Acquir Immune Defic Syndr. 2001 Sep 1;28(1):65-72.

PMID:
11579279

Supplemental Content

Support Center